Cochlear Limited (ASX:COH)
| Market Cap | 13.01B -27.7% |
| Revenue (ttm) | 2.34B +1.3% |
| Net Income | 345.30M -6.8% |
| EPS | 5.27 -6.6% |
| Shares Out | 65.40M |
| PE Ratio | 37.78 |
| Forward PE | 29.92 |
| Dividend | 4.30 (2.16%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 189,324 |
| Average Volume | 214,838 |
| Open | 197.00 |
| Previous Close | 199.01 |
| Day's Range | 195.32 - 202.19 |
| 52-Week Range | 191.11 - 319.56 |
| Beta | 0.51 |
| RSI | 24.67 |
| Earnings Date | Feb 13, 2026 |
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered i... [Read more]
Financial Performance
In fiscal year 2025, Cochlear's revenue was 2.34 billion, an increase of 4.81% compared to the previous year's 2.24 billion. Earnings were 388.90 million, an increase of 9.00%.
Financial StatementsNews
Cochlear implant done on 3-year-old
Mangaluru: In a step forward in advanced hearing restoration, the department of ENT, head and neck, cochlear implant and skull-base surgery at Yenepoy.
Cochlear North America Celebrates International Cochlear Implant Day with Announcement of 2026 Academic Scholarship Recipients
LONE TREE, Colo., Feb. 25, 2026 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is proud to announce the recipients of the 2026 Cochlear Academic Scholarsh...
Cochlear reports 1H results
Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript
Cochlear Limited (CHEOY) Q2 2026 Earnings Call Transcript
Cochlear CEO: AUD currency fluctuations weighing on earnings
Dig Howitt, the CEO of Cochlear, also talks about how the company navigates tariff and supply chain issues, and the new Nucleus Nexa "smart" implant.
Cochlear Ltd (CHEOF) (Half Year 2026) Earnings Call Highlights: Navigating Challenges and ...
Cochlear Ltd (CHEOF) (Half Year 2026) Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities
Half Year 2026 Cochlear Ltd Earnings Call Transcript
Half Year 2026 Cochlear Ltd Earnings Call Transcript
Cochlear Limited 2026 Q2 - Results - Earnings Call Presentation
Cochlear lowers guidance after delays to new implant rollout
The medical device maker expects full-year earnings to land near the bottom end of the previously forecast range, and has written down its investment in Saluda.
Cochlear shares hit three-year low on new implant delays
The medical device maker expects full-year earnings to land near the bottom end of its forecast range, and has written down its investment in Saluda.
ASX 200 LIVE: ASX drops 1.3pc on AI rout; Austal, WiseTech sink
AI fears and precious metals fall weigh; Cochlear trims guidance; Webjet ends takeover talks; Wesfarmers in Microsoft AI deal; Westpac profit up; Virgin names new Velocity boss. Follow live
Cochlear implants activated soon after surgery to speed up recovery
Chennai: Doctors at MGM Healthcare performed simultaneous bilateral cochlear implants on a 35-year-old techie, activating both devices immediately aft.
Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to elig...
MRI 3T Cochlear Implant Market Poised for 9.96% CAGR Growth, North America Leads
Ottawa, Dec. 10, 2025 (GLOBE NEWSWIRE) -- The global MRI 3T cochlear implant market size is calculated at USD 902.78 million in 2025 and is expected to reach around USD 2101.54 million by 2034, growi...
MED-EL Cochlear Implant Becomes First FDA-Approved Option for Children Seven Months and Older
DURHAM, N.C.--(BUSINESS WIRE)-- #FDAapproval--FDA approves expanded indication for MED-EL cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
Cochlear Limited (CHEOF) Q4 2025 Earnings Call Transcript
Cochlear Limited (OTCPK:CHEOF) Q4 2025 Earnings Conference Call August 14, 2025 8:00 PM ET Company Participants Diggory William Howitt - CEO, MD, President & Executive Director Sarah Thom - Chief Fina...
Cochlear Launches World's First and Only Smart Cochlear Implant System
Upgradeable Firmware: The Cochlear™ Nucleus® Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates. Sm...
Starkey and MED-EL Announce All-New DualSync Partnership to Advance Bluetooth Connectivity for Cochlear Implant Users
DURHAM, N.C.--(BUSINESS WIRE)-- #audiology--Driven by a shared commitment to advancing hearing health, global hearing technology leaders Starkey and MED-EL are bringing their exclusive collaboration t...
Cochlear introduces the Baha® 7 Sound Processor and Baha SoundBand™
NEW Baha® 7 Sound Processor: First in bone conduction to enable Bluetooth® LE Audio* and Auracast™ broadcast audio streaming capabilities1, 2. NEW Baha SoundBand ™ : Improved look and fitting options ...
Hearing Implants Global Strategic Business Report 2025: Market to Reach $4.9 Billion by 2030 - Increasing Adoption of Cochlear Implants Expands Opportunities
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Hearing Implants - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Hearing Implants ...
Assessment of the $6.63 Billion Cochlear Implants Market, 2034: Emerging Markets, such as Asia-Pacific, Latin America and Africa, Present a Significant Growth Opportunity
Dublin, March 12, 2025 (GLOBE NEWSWIRE) -- The "Cochlear Implants Market - A Global and Regional Analysis: Focus on Patient Type, End User, and Region - Analysis and Forecast, 2024-2034" report has be...
Cochlear Named Most Trustworthy Healthcare Company in the World
LONE TREE, Colo. , March 3, 2025 /PRNewswire/ -- In celebration of World Hearing Day, Cochlear, the global leader in implantable hearing solutions, is proud to announce that it has been named the numb...
Cochlear North America Celebrates International Cochlear Implant Day by Announcing 2025 Academic Scholarship Winners
LONE TREE, Colo. , Feb. 25, 2025 /PRNewswire/ -- In celebration of International Cochlear Implant Day, Cochlear North America is thrilled to announce the winners of 2025 annual Cochlear Academic Schol...
Cochlear Implants Market to Hit US$4.73 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™.
Delray Beach, FL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The global cochlear implants market valued at US$2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$2.80 Billion in 2...
Cochlear CEO on tariffs: 'Watch and wait' to see what happens
Dig Howitt, CEO and President of Cochlear, discusses the company's half-year earnings, potential impact of tariffs on the business, and the plunge in the company's share price.